GGrantIndex
← Leaderboards

Swati Kulkarni

Roswell Park Cancer Institute Corp

$4,052,632
Attributed
$4,376,369
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $685.2K · FY200821
$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$4,376,369 · 3

By mechanism

R01$3,138,725 · 1
R21$1,237,644 · 2

Top collaborators

Most similar at Roswell Park Cancer Institute Corp

Same institution · by research overlap

Others in their field

Top investigators on “Prevent

Research focus

PreventWomanOperative Surgical ProceduresAffectEstrogensBaseMalignant Breast NeoplasmRandomizedGenesSamplingEstrogen Receptor PositiveEpithelial CellsBreastBiopsyProteinsIn VivoPathway InteractionsEstrogen ReceptorsEpitheliumErbb2 GeneNewly DiagnosedDiagnosticFda ApprovedMonitor

Grant awards (11)

Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ$480,703
R01 · FY2021 · CA · contact PI
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ$683,130
R01 · FY2020 · CA · contact PI
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ$650,068
R01 · FY2019 · CA · contact PI
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ$685,186
R01 · FY2018 · CA · contact PI
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ$639,638
R01 · FY2017 · CA · contact PI
Role of Estrogen Receptor alpha-p53 Interaction in Resistance to Tamoxifen Therap$325,629
R21 · FY2010 · CA
A study evaluating the effect of flaxseed on biomarkers of breast cancer risk$152,626
R21 · FY2010 · CA · contact PI
A study evaluating the effect of flaxseed on biomarkers of breast cancer risk$38,875
R21 · FY2010 · CA · contact PI
Role of Estrogen Receptor alpha-p53 Interaction in Resistance to Tamoxifen Therap$321,845
R21 · FY2009 · CA
A study evaluating the effect of flaxseed on biomarkers of breast cancer risk$189,202
R21 · FY2009 · CA · contact PI
A study evaluating the effect of flaxseed on biomarkers of breast cancer risk$209,467
R21 · FY2008 · CA · contact PI